Skip to main content

Table 2 Characteristics of the study population

From: Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7

  Total CHD population
(n = 1483)
MI
(n = 753)
PCI and/or CABG, but no MI
(n = 604)
AP, but no MI, PCI or CABG
(n = 126)
Sex, n (%)         
 Women 446 (30.1) 174 (23.1) 203 (33.6) 69 (54.8)
Age, mean (sd) 68.7 (10.8) 69.2 (10.1) 69.2 (10.6) 63.0 (13.7)
Smoking, n (%)         
 Daily smoking 182 (12.3) 96 (12.7) 67 (11.1) 19 (15.1)
 Smoked previously 860 (58.0) 472 (62.7) 334 (55.3) 54 (42.9)
Self-reported health, n (%)         
 Excellent/good 705 (47.5) 343 (45.6) 311 (51.5) 51 (40.5)
 Neither good nor bad 602 (40.6) 318 (42.2) 232 (38.4) 52 (41.3)
 Bad/very bad 153 (10.3) 79 (10.5) 53 (8.8) 21 (16.7)
Comorbidities*, n (%)         
 Hypertension 827 (55.8) 433 (57.5) 328 (54.3) 66 (52.4)
 Heart failure 231 (15.6) 126 (16.7) 94 (15.6) 11 (8.7)
 Atrial fibrillation 283 (19.1) 138 (18.3) 111 (18.4) 34 (27.0)
 Stroke 123 (8.3) 65 (8.6) 49 (8.1) 9 (7.1)
 Diabetes 214 (14.4) 123 (16.3) 80 (13.2) 11 (8.7)
 Renal disease 114 (7.7) 68 (9.0) 35 (5.6) 11 (8.7)
 Cancer 189 (12.7) 101 (13.4) 77 (12.7) 11 (8.7)
Medications, mean number of products (sd) 4.0 (2.9) 4.3 (3.0) 3.8 (2.8) 3.0 (2.9)
Clinical measurements, mean (sd)
 Systolic blood pressure, mmHg 136 (20.9) 135 (21.7) 137 (19.9) 133 (20.3)
 Diastolic blood pressure, mmHg 74 (9.9) 75 (10.0) 74 (9.6) 76 (10.1)
 Total cholesterol, mmol/l 4.6 (1.1) 4.5 (1.1) 4.7 (1.1) 5.6 (1.3)
 LDL-cholesterol, mmol/l 2.9 (1.0) 2.7 (1.0) 2.9 (1.0) 3.7 (1.2)
 HDL-cholesterol, mmol/l 1.4 (0.4) 1.4 (0.4) 1.5 (0.5) 1.5 (0.4)
 Triglycerides, mmol/l 1.6 (1.0) 1.7 (1.0) 1.5 (0.8) 1.8 (0.9)
 HbA1c, % 6.1 (0.9) 6.1 (1.0) 6.0 (0.8) 5.8 (0.5)
 Glucose, mmol/l§ 6.0 (2.1) 6.2 (2.3) 6.0 (1.9) 5.6 (1.3)
 BMI, kg/m2 28.4 (4.5) 28.5 (4.4) 28.1 (4.4) 28.7 (5.2)
  1. AP, angina pectoris; BMI, body mass index; CABG, coronary artery bypass graft; CHD, coronary heart disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; PCI, percutaneous coronary intervention; sd, standard deviation
  2. *Self-reported relevant comorbidities for coronary heart disease, present or previous diseases. For diabetes: present disease or use of any antidiabetic drug
  3. To convert to mg/dL, multiply with 38.67
  4. To convert to mg/dL, multiply with 88.57
  5. §To convert to mg/dL, multiply with 18.02